HomeInsightsPE

Gujarat Themis Biosyn Ltd P/E Ratio

Gujarat Themis Biosyn Ltd P/E Ratio

download
stocks purchased

₹ 1.5 Cr

Volume transacted

stocks purchased

30.3 K

stocks traded

Last Updated time: 24 Jul 9.00 AM

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

PE

57.7

Last updated : 24 Jul 9.00 AM

Key Highlights

    The P/E Ratio of Gujarat Themis Biosyn Ltd is 57.7 as of 24 Jul 9.00 AM .a1#The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 8.9 on March 2019 to 9.7 on March 2024 . This represents a CAGR of 1.44% over 6 years. a1#The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 494.45 as of 24 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.3 to 27.3 in 5 years. This represents a CAGR of -0.72%a1# The PE Ratio of Automobile industry is 18.9. The PE Ratio of Finance industry is 23.5. The PE Ratio of IT - Software industry is 29.4. The PE Ratio of Pharmaceuticals industry is 38.5. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.5. In 2024a1#The Market Cap of Gujarat Themis Biosyn Ltd changed from ₹ 57.1 crore on March 2019 to ₹ 2877 crore on March 2024 . This represents a CAGR of 92.19% over 6 years. a1#The Revenue of Gujarat Themis Biosyn Ltd changed from ₹ 46.37 crore to ₹ 43.03 crore over 8 quarters. This represents a CAGR of -3.67% a1#The EBITDA of Gujarat Themis Biosyn Ltd changed from ₹ 24.2 crore to ₹ 21.95 crore over 8 quarters. This represents a CAGR of -4.76% a1#The Net Pr of Gujarat Themis Biosyn Ltd changed from ₹ 17.77 crore to ₹ 15.89 crore over 8 quarters. This represents a CAGR of -5.44% a1#The Dividend Payout of Gujarat Themis Biosyn Ltd changed from 10.12 % on March 2019 to 12.27 % on March 2024 . This represents a CAGR of 3.93% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Gujarat Themis Biosyn Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Gujarat Themis Biosyn Ltd

Period
Mar '198.9
Mar '206
Mar '219.8
Mar '2213.6
Mar '2317.2
Mar '249.7

Company Fundamentals for Gujarat Themis Biosyn Ltd

Market Cap

3,591 Cr

EPS

8.1

P/E Ratio (TTM) *

57.7

P/B Ratio (TTM) *

16.9

Day’s High

498.0

Day’s Low

468.2

DTE *

0.0

ROE *

29.4

52 Week High

530.0

52 Week Low

152.22

ROCE *

39.0

* All values are consolidated

Last Updated time: 24 Jul 9.00 AM

* All values are consolidated

Last Updated time: 24 Jul 9.00 AM

Image

Gujarat Themis Biosyn Ltd

NSE: GUJTHEMIS

PRICE

494.45

24.95 (5.31%)

stock direction

Last updated : 24 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Gujarat Themis Biosyn Ltd

Market Value

3,411

Asset Value

48

70.1 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Gujarat Themis Biosyn Ltd573,410
Sun Pharmaceuticals Industries Ltd38384,469
Cipla Ltd28120,922
Divis Laboratories Ltd74119,968
Zydus Lifesciences Ltd30115,601
Dr Reddys Laboratories Ltd20114,525

Key Valuation Metric of Gujarat Themis Biosyn Ltd

Earnings

59 Cr

57.7 X

PE Ratio

Market Cap

₹3410Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

59 Cr

57.7 X

PE Ratio

Market Cap

₹3410Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Gujarat Themis Biosyn Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Gujarat Themis Biosyn Ltd

Period
Mar '1957
Mar '20141
Mar '21296
Mar '22592
Mar '23997
Mar '242877

* All values are a in crore

×

Historical Revenue of Gujarat Themis Biosyn Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Gujarat Themis Biosyn Ltd

Period
Jun '2246
Sep '2249
Dec '2230
Mar '2330
Jun '2351
Sep '2341
Dec '2340
Mar '2443

* All values are a in crore

×

Historical EBITDA of Gujarat Themis Biosyn Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Gujarat Themis Biosyn Ltd

Period
Jun '2224
Sep '2226
Dec '2214
Mar '2316
Jun '2325
Sep '2318
Dec '2319
Mar '2422

* All values are a in crore

×

Historical Net Profit of Gujarat Themis Biosyn Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Gujarat Themis Biosyn Ltd

Period
Jun '2218
Sep '2219
Dec '2210
Mar '2312
Jun '2318
Sep '2313
Dec '2313
Mar '2416

* All values are a in crore

×

Historical Dividend Payout of Gujarat Themis Biosyn Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Gujarat Themis Biosyn Ltd

Period
Mar '190
Mar '2010
Mar '210
Mar '2237
Mar '2314
Mar '2412

* All values are a in %

About Gujarat Themis Biosyn Ltd

About Gujarat Themis Biosyn Ltd

    Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990. However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990. Subsequently, it was taken over by a group consisting of Lyka Labs, Themis Chemicals, Kopran and Cadila. Also, Yuhan Corporation, South Korea, brought in technology and finance for running GTBL. During 1995-96 the paid-up share capital increased from Rs 11.25 crores to Rs 11.60 crores after allotment of 350,000 Equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions by way of conversion of fund interst term loan. During the year installed capacity of rifamysin-S was increased to 90 mtpa and expansion of rifampicin was achieved to the maximum capacity of 120 mtpa. It also commenced operations of its new pharmaceutical division and launched a wide range of anti-tuberculosis products and other antibiotics. The company is constantly identifying new areas for diversification and also capacity expansion of exisiting product in order to further reduction in cost of production and increase in turnover.

Gujarat Themis Biosyn Ltd News Hub

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 26 J...

Read more

17 Jul 202410:09

News

Board of Gujarat Themis Biosyn recommends Final Dividend

Gujarat Themis Biosyn announced that the Board of Directors of the Company at its meeting ...

Read more

14 May 202415:48

News

Gujarat Themis Biosyn to convene AGM

Gujarat Themis Biosyn announced that the 43th Annual General Meeting(AGM) of the company w...

Read more

14 May 202417:12

News

Gujarat Themis Biosyn to convene board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 14 M...

Read more

03 May 202417:43

News

Board of Gujarat Themis Biosyn recommends Interim Dividend

Gujarat Themis Biosyn announced that the Board of Directors of the Company at its meeting ...

Read more

10 Feb 202415:41

News

Gujarat Themis Biosyn announces board meeting date

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 10 F...

Read more

30 Jan 202413:51

Product Composition by Percentage (Revenue)

FAQs for PE of Gujarat Themis Biosyn Ltd

What is Gujarat Themis Biosyn Ltd current share price?

The current market price of Gujarat Themis Biosyn Ltd as of July 24, 2024 is ₹494.45.

What is Gujarat Themis Biosyn Ltd's market cap?

Gujarat Themis Biosyn Ltd's market capitalisation stood at ₹3,410 Cr as of July 24, 2024

What are Gujarat Themis Biosyn Ltd's total net assets?

According to Gujarat Themis Biosyn Ltd's most recent financial filings, the company's net assets total ₹48.0 Cr.

Is Gujarat Themis Biosyn Ltd making a profit or loss?

Gujarat Themis Biosyn Ltd's net Profit as of July 24, 2024 is close to ₹59 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199